[HTML][HTML] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia

SG Deeks, T Wrin, T Liegler, R Hoh… - … England Journal of …, 2001 - Mass Medical Soc
Background In many patients with human immunodeficiency virus (HIV) infection, therapy
with potent antiretroviral drugs does not result in complete suppression of HIV replication. The …

Defective proviruses rapidly accumulate during acute HIV-1 infection

…, AA Capoferri, J Lai, MC Strain, SM Lada, R Hoh… - Nature medicine, 2016 - nature.com
Although antiretroviral therapy (ART) suppresses viral replication to clinically undetectable
levels, human immunodeficiency virus type 1 (HIV-1) persists in CD4 + T cells in a latent form …

Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection

…, CA Forman, SE Munter, R Hoh… - The Journal of …, 2021 - academic.oup.com
Background The biological processes associated with postacute sequelae of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) are unknown. Methods …

[HTML][HTML] Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

…, S Chioma, F Emad, M Abdel-Mohsen, R Hoh… - PLoS …, 2013 - journals.plos.org
HIV-1 reservoirs preclude virus eradication in patients receiving highly active antiretroviral
therapy (HAART). The best characterized reservoir is a small, difficult-to-quantify pool of …

[HTML][HTML] Chronic viral coinfections differentially affect the likelihood of developing long COVID

…, F Chan, S Lu, SA Goldberg, R Hoh… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND The presence and reactivation of chronic viral infections, such as EBV, CMV,
and HIV, have been proposed as potential contributors to long COVID (LC), but studies in …

[HTML][HTML] CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

…, S DaFonseca, M Killian, L Epling, R Hoh… - PLoS …, 2016 - journals.plos.org
HIV persists in a small pool of latently infected cells despite antiretroviral therapy (ART).
Identifying cellular markers expressed at the surface of these cells may lead to novel therapeutic …

Distinct viral reservoirs in individuals with spontaneous control of HIV-1

…, K Chang, JE Blackmer, M Osborn, MJ Peluso, R Hoh… - Nature, 2020 - nature.com
Sustained, drug-free control of HIV-1 replication is naturally achieved in less than 0.5% of
infected individuals (here termed ‘elite controllers’), despite the presence of a replication-…

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

PY Hsue, PW Hunt, A Schnell, SC Kalapus, R Hoh… - Aids, 2009 - journals.lww.com
Objective: HIV-seropositive patients are at higher risk for atherosclerosis than HIV-seronegative
persons. This has been variably attributed to antiretroviral drug toxicity, …

[HTML][HTML] A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

…, KL Lynch, C Yun, CT Maguire, MJ Peluso, R Hoh… - Nature, 2023 - nature.com
Studies have demonstrated that at least 20% of individuals infected with SARS-CoV-2 remain
asymptomatic 1 , 2 , 3 – 4 . Although most global efforts have focused on severe illness in …

[PDF][PDF] Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants

…, L Odevall, JM Milush, T Liegler, E Sinclair, R Hoh… - Cell reports, 2017 - cell.com
Latent replication-competent HIV-1 persists in individuals on long-term antiretroviral therapy
(ART). We developed the Full-Length Individual Proviral Sequencing (FLIPS) assay to …